A message of thanks from our CEO, Doug Hawkins
For Australians, 2020 will perhaps be remembered as one of the most demanding and difficult years in recent history.
National Pancreatic Cancer Roadmap Community Consultation Now Open
It's time to have your say. Community consultation on the development of the National Pancreatic Cancer Roadmap now open.
Floorworld in partnership with Pancare Foundation – laying the foundations for impacting the cause
Pancare Foundation are thrilled to announce a new, national partnership with specialty flooring retailer Floorworld, to take on Australia’s toughest cancers – upper gastrointestinal cancers.
Ads on Wheels and Grow Business Group in partnership with Pancare Foundation – a driving force for change
Pancare Foundation are thrilled to welcome new corporate partners, the dynamic duo of Ads on Wheels and Grow Business Group, in the fight against upper gastrointestinal (GI) cancers.
World-first Funding for New Liver Cancer Therapy
Pancare Foundation welcomes the news that a new combination therapy for liver cancer will be added to the Australian Pharmaceutical Benefits Scheme.
Pancare Foundation expands resources available to patients living with pancreatic cancer
Pancare Foundation are proud to announce the transition of ownership and management of dedicated pancreatic cancer website, PanSupport, from the University of Melbourne.
Pancreatic Cancer Familial Screening Program Update
We were fortunate to have Tanya Dwarte, Clinical Research Coordinator from the Garvan Institute of Medical Research, present on the Pancreatic Cancer Familial Screening Program for high-risk individuals, at our recent online Patient Support Group.
Latest data provides hope for Upper GI cancers with increases in 5-year survival
Latest data from the Australian Institute of Health and Welfare (AIHW) confirms that the incidence of upper gastrointestinal cancers in Australia are on the rise. While these figures are concerning, there is hope for those diagnosed, with the five-year survival rates for pancreatic cancer patients now hitting double digits for the first time at 10.7%.